Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332410 · ClinicalTrials.gov registry record
Intravenous Voriconazole in Patients With Renal Compromise
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 150
- Enrollment target
NCT00332410 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 150 participants.
The verdict
NCT00332410 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients with compromised renal function (CrCl \< 50mL/min) receiving intravenous voriconazole experienced any adverse effects related to serum chemistries or other imaging studies of the kidney due to the potential accumulation of the vehicle cyclodextran.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2006-05 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332410
The ClinicalTrials.gov registry entry for NCT00332410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00332410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332410 about?
NCT00332410 is a clinical study titled "Intravenous Voriconazole in Patients With Renal Compromise". The purpose of this study is to determine whether patients with compromised renal function (CrCl \< 50mL/min) receiving intravenous voriconazole experienced any adverse effects related to serum chemistries or other imaging studies of the kidney due to the potential accumulation of the vehicle cyclod...
What is the current status of trial NCT00332410?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2006-05. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00332410?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.